• Je něco špatně v tomto záznamu ?

Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing

M. Donati, L. Kastnerova, P. Martinek, P. Grossmann, E. Sticová, L. Hadravský, T. Torday, J. Kyclova, M. Michal, DV. Kazakov,

. 2020 ; 42 (2) : 92-102. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028530

Spitz tumors represent a heterogeneous group of melanocytic neoplasms with a spectrum of biological behavior ranging from benign (Spitz nevus) to malignant (spitzoid melanoma). Prediction of the behavior of these lesions based on their histological presentation is not always possible. Recently, mutually exclusive activating kinase fusions, involving ALK, NTRK1, NTRK3, RET, MET, ROS1, and BRAF, have been found in a subset of spitzoid lesions. Some of these genetic alterations were associated with specific morphological features. Here, we report the histological presentation of 6 Spitz tumors with ROS1 fusion. The age of the patients ranged from 6 to 34 years, with strong female prevalence (5:1). All neoplasms were compound melanocytic proliferations with a predominant dermal growth but a conspicuous junctional component displaying atypical microscopic features qualifying them as atypical Spitz tumor. FIP1L1 and CAPRIN1 were identified as 2 novel 5'-fusion partners of ROS1 along with the known PWWP2A-ROS1 fusion. FISH for copy number changes of 9p21, 6p25, and 11q13 was negative in all but 1 neoplasm harboring isolated gain of 8q24. TERT-promoter hotspot mutation analysis was negative in all tumors. All patients are disease-free after a mean follow-up period of 30 months. It is concluded that ROS1-fused spitzoid neoplasms seem to have no distinctive histopathological features although consistent findings were spindled melanocytes arranged in confluent whorling nests, prominent transepidermal elimination of melanocytic nests, and myxoid/mucinous changes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028530
003      
CZ-PrNML
005      
20210114154146.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/DAD.0000000000001499 $2 doi
035    __
$a (PubMed)31361613
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Donati, Michele $u Department of Pathology, University Hospital Campus Bio-Medico, Rome, Italy.
245    10
$a Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing / $c M. Donati, L. Kastnerova, P. Martinek, P. Grossmann, E. Sticová, L. Hadravský, T. Torday, J. Kyclova, M. Michal, DV. Kazakov,
520    9_
$a Spitz tumors represent a heterogeneous group of melanocytic neoplasms with a spectrum of biological behavior ranging from benign (Spitz nevus) to malignant (spitzoid melanoma). Prediction of the behavior of these lesions based on their histological presentation is not always possible. Recently, mutually exclusive activating kinase fusions, involving ALK, NTRK1, NTRK3, RET, MET, ROS1, and BRAF, have been found in a subset of spitzoid lesions. Some of these genetic alterations were associated with specific morphological features. Here, we report the histological presentation of 6 Spitz tumors with ROS1 fusion. The age of the patients ranged from 6 to 34 years, with strong female prevalence (5:1). All neoplasms were compound melanocytic proliferations with a predominant dermal growth but a conspicuous junctional component displaying atypical microscopic features qualifying them as atypical Spitz tumor. FIP1L1 and CAPRIN1 were identified as 2 novel 5'-fusion partners of ROS1 along with the known PWWP2A-ROS1 fusion. FISH for copy number changes of 9p21, 6p25, and 11q13 was negative in all but 1 neoplasm harboring isolated gain of 8q24. TERT-promoter hotspot mutation analysis was negative in all tumors. All patients are disease-free after a mean follow-up period of 30 months. It is concluded that ROS1-fused spitzoid neoplasms seem to have no distinctive histopathological features although consistent findings were spindled melanocytes arranged in confluent whorling nests, prominent transepidermal elimination of melanocytic nests, and myxoid/mucinous changes.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a proteiny buněčného cyklu $x genetika $7 D018797
650    _2
$a dítě $7 D002648
650    _2
$a chromozomální proteiny, nehistonové $x genetika $7 D002868
650    _2
$a variabilita počtu kopií segmentů DNA $7 D056915
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a hybridizace in situ fluorescenční $7 D017404
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melanom $x genetika $x patologie $7 D008545
650    _2
$a epiteloidní a vřetenobuněčný névus $x genetika $x patologie $7 D018332
650    _2
$a onkogenní fúze $7 D050596
650    _2
$a tyrosinkinasy $x genetika $7 D011505
650    _2
$a protoonkogenní proteiny $x genetika $7 D011518
650    _2
$a nádory kůže $x genetika $x patologie $7 D012878
650    _2
$a telomerasa $x genetika $7 D019098
650    _2
$a mladý dospělý $7 D055815
650    _2
$a faktory štěpení a polyadenylace mRNA $x genetika $7 D039221
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kastnerova, Liubov $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Bioptical Laboratory, Pilsen, Czech Republic.
700    1_
$a Martinek, Petr $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Bioptical Laboratory, Pilsen, Czech Republic.
700    1_
$a Grossmann, Petr $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Bioptical Laboratory, Pilsen, Czech Republic.
700    1_
$a Sticová, Eva $u Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Hadravský, Ladislav $u Department of Pathology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Torday, Tomas $u Medicyt Laboratory, Kosice, Slovakia.
700    1_
$a Kyclova, Jitka $u Department of Pathology, University Hospital, Brno, Czech Republic.
700    1_
$a Michal, Michal $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Bioptical Laboratory, Pilsen, Czech Republic.
700    1_
$a Kazakov, Dmitry V $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Bioptical Laboratory, Pilsen, Czech Republic.
773    0_
$w MED00000240 $t The American Journal of dermatopathology $x 1533-0311 $g Roč. 42, č. 2 (2020), s. 92-102
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31361613 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154143 $b ABA008
999    __
$a ok $b bmc $g 1608865 $s 1119710
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 42 $c 2 $d 92-102 $e - $i 1533-0311 $m The American journal of dermatopathology $n Am J Dermatopathol $x MED00000240
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace